Cargando…
First person – John (Eddie) Edmund La Marca
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. John La Marca is first author on ‘ A Drosophila chemical screen reveals synergistic effect of MEK and DG...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110404/ http://dx.doi.org/10.1242/dmm.050179 |
_version_ | 1785027256922406912 |
---|---|
collection | PubMed |
description | First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. John La Marca is first author on ‘ A Drosophila chemical screen reveals synergistic effect of MEK and DGKa inhibition in Ras-driven cancer’, published in DMM. John conducted the research described in this article while a research officer in Helena Richardson's lab at La Trobe University, Bundoora, Australia. He is now a research officer in the lab of Gemma Kelly and Marco Herold at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia, investigating genetics, cancer and molecular signalling. |
format | Online Article Text |
id | pubmed-10110404 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-101104042023-04-18 First person – John (Eddie) Edmund La Marca Dis Model Mech First Person First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. John La Marca is first author on ‘ A Drosophila chemical screen reveals synergistic effect of MEK and DGKa inhibition in Ras-driven cancer’, published in DMM. John conducted the research described in this article while a research officer in Helena Richardson's lab at La Trobe University, Bundoora, Australia. He is now a research officer in the lab of Gemma Kelly and Marco Herold at the Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia, investigating genetics, cancer and molecular signalling. The Company of Biologists Ltd 2023-04-03 /pmc/articles/PMC10110404/ http://dx.doi.org/10.1242/dmm.050179 Text en © 2023. Published by The Company of Biologists Ltd https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | First Person First person – John (Eddie) Edmund La Marca |
title | First person – John (Eddie) Edmund La Marca |
title_full | First person – John (Eddie) Edmund La Marca |
title_fullStr | First person – John (Eddie) Edmund La Marca |
title_full_unstemmed | First person – John (Eddie) Edmund La Marca |
title_short | First person – John (Eddie) Edmund La Marca |
title_sort | first person – john (eddie) edmund la marca |
topic | First Person |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10110404/ http://dx.doi.org/10.1242/dmm.050179 |